Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 13/20 | 0.68 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.65 |
| ▸ | CCKBR | P32239 | 1/20 | 0.65 |
| ▸ | ECE1 | P42892 | 1/20 | 0.65 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.65 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.62 |
| ▸ | CCKAR | P32238 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2742706 | 0.96 | NR3C1 (0.70) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL2759455 | 0.96 | NR3C1 (0.70) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL10083215 | 0.92 | GLP1R (0.70) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL2752275 | 0.92 | GLP1R (0.70) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL6123960 | 0.91 | GLP1R (0.69) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL15086005 | 0.88 | GLP1R (0.67) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL15024692 | 0.87 | GLP1R (0.67) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL14769532 | 0.87 | GLP1R (0.67) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL29358622 | 0.87 | GLP1R (0.82) | GLP1RNR3C1CCKBRECE1MUS81 | |
| SCHEMBL11932912 | 0.87 | TFPI (0.64) | GLP1RNR3C1CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173674-B2 | Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals | SANOFI-AVENTIS (FR) | 2012-05-08 | — | — | US | disclosed |